4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-21-000111
Chief Executive Officer acquired 55,736 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mallon Mark · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-19 | Grant or award : show line 1 in the form | +55,736 | 55,736 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-04-19 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +151,016 | $49.34 | 2028-04-19 | 151,016 | 151,016 | D |
Loading xslF345X03/wf-form4_161904358115470.xml…